Tina lived a healthy lifestyle and wanted to live as long as she could. A rare cancer diagnosis called cholangiocarcinoma threatened her dreams. Tina’s oncologist recommended a clinical trial that combined chemotherapy and immunotherapy. She details how the treatment extended her life and why patients must advocate for themselves.
New Immunotherapies Bring Hope to Patients with Rare Liver Cancers
Stay up to date
Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
